Statistics
Publications
4
Citations
92
H-Index
4
Active since
2017
Yangjiong Xiao is an author at Xian Central Hospital specializing in oncology, cancer cell signaling, and molecular oncology.
Publications per year
2017–2021
4
4
The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis
Yangjiong Xiao, Yang Yu, Pengcheng Jiang et al. · Cellular Oncology · 2020 · 37 citations · Full text
Medicine, Cancer Biology, Oncology +14
Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer
Yangjiong Xiao, Yang Yu, Dan Gao et al. · Frontiers in Oncology · 2019 · 22 citations · Full text
Medicine, Oncology, Pharmacology +17
RNF7 knockdown inhibits prostate cancer tumorigenesis by inactivation of ERK1/2 pathway
Yangjiong Xiao, Yan Jiang, Hongmei Song et al. · Scientific Reports · 2017 · 20 citations · Full text
1–4 of 4